# FDA Inspection 796524 - Regenerative Biologics, Inc. - August 29, 2012

Source: https://www.keypedia.com/records/fda_inspections/regenerative-biologics-inc/4f1d8c3e-78cd-48ca-8272-07f312b1f22a
Source feed: FDA_Inspections

> FDA Inspection 796524 for Regenerative Biologics, Inc. on August 29, 2012. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 796524
- Company Name: Regenerative Biologics, Inc.
- Inspection Date: 2012-08-29
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 924832 - 2015-05-05](https://www.keypedia.com/records/fda_inspections/regenerative-biologics-inc/6b356b98-ff64-472b-b75b-36909f44a1a6)
- [FDA Inspection 671922 - 2010-07-14](https://www.keypedia.com/records/fda_inspections/regenerative-biologics-inc/aa809689-3db8-444e-b883-35d3f9d76c34)

Company: https://www.keypedia.com/companies/regenerative-biologics-inc/ac5a4c9e-d434-4dc4-be46-376c0ee7e00e

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d